Don’t waste time

At ECNP 2017, Prof Hamish McAllister-Williams, Newcastle University, UK, provided an in-depth review of the available treatment options to tackle depression, and the strength of evidence for each approach. He emphasised that, in addition to the treatment option chosen, it is how treatment is approached that is crucial.

Treat effectively early

The STAR*D study shows that with successive treatment steps, response goes down. In this study, outpatients with nonpsychotic MDD were given one (3671 patients) to four (123) successive acute treatment steps. The remission rates, assessed using  QIDS-SR(16), were 36%, 31%, 14% and 13% for the first, second, third and fourth treatment steps, respectively.

This highlights that we need to treat patients effectively as early as possible. Don’t wait. Don’t waste time. Also, if something isn’t working - do something.

We need to treat patients effectively as early as possible

Measurement-based care

Prof McAllister-Williams suggested that measurement-based care may have a place in the clinical care of patients with MDD.

A randomised controlled trial compared measurement-based care (guideline- and rating scale-based decisions) with standard treatment (clinicians' choice) in MDD. Over 24 weeks, outpatients with moderate to severe MDD were treated with either measurement-based care (61 patients) or standard treatment (59 patients). The HAM-D and QIDS-SR were used to assess depressive symptoms.

In the measurement-based care group, there were significantly more treatment adjustments (44 versus 23) and higher doses of antidepressants.

Patients in the measurement-based care group generally did better than those in standard care, with significantly more patients achieving response (87% versus 63%) and remission (74% versus 29%).

Bring your patients on board

Give them confidence it is the best treatment plan for them

Yes, we need to have a clear treatment plan, but we also need to have confidence in that plan, Prof McAllister-Williams reminded us. We need to bring our patients on board with their journey to recovery, and give them confidence it is the best treatment plan for them.

Key

HAM-D, Hamilton Depression Rating Scale; MDD, major depressive disorder; QIDS-SR(16), Quick Inventory of Depressive Symptomatology-Self-Report; STAR*D, Sequenced Treatment Alternatives to Relieve Depression.

References
  1. Rush AJ et al. Am J Psychiatry, 2006;163:1905-17.
  2. Guo T et al. Am J Psychiatry, 2015;172:1004-13.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country